Chorda Pharma Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Angel

  • Latest Deal Amount
  • $200K

  • Investors
  • 3

Chorda Pharma General Information

Description

Operator of a pharmaceutical company intended to treat arthritis, diabetic neuropathy, sports injuries, and other ailments requiring long-term treatment to relieve pain. The company's medications are opioid-free and are used as an alternative to traditional prescription-based pain relievers, like opioids, and provide a pipeline of proprietary analgesics for managing chronic pain, enabling patients to get treated without having to consume harmful drugs and pain relievers.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 709 South Jefferson Street
  • Suite 301
  • Roanoke, VA 24016
  • United States
+1 (540)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Corporate Office
  • 709 South Jefferson Street
  • Suite 301
  • Roanoke, VA 24016
  • United States
+1 (540)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Chorda Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Angel (individual) 20-Dec-2024 $200K Completed Generating Revenue
3. Grant 27-Jun-2022 Completed Generating Revenue
2. Angel (individual) 26-Apr-2022 $292K $312K Completed Generating Revenue
1. Accelerator/Incubator 15-May-2018 $20K $20K Completed Generating Revenue
To view Chorda Pharma’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Chorda Pharma Patents

Chorda Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4733295-A1 Stable forms of capsaicin palmitate for the treatment of pain Pending 25-Oct-2024
JP-2026077618-A Stable forms of capsaicin palmitate for the treatment of pain Pending 25-Oct-2024
US-12458611-B1 Stable forms of capsaicin palmitate for the treatment of pain Active 25-Oct-2024
US-20260115155-A1 Stable forms of capsaicin palmitate for the treatment of pain Pending 25-Oct-2024
WO-2024243507-A2 Solid forms of capsaicin palmitate for the treatment of pain Inactive 24-May-2023 C07C53/126
To view Chorda Pharma’s complete patent history, request access »

Chorda Pharma Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Common Wealth Angels Angel Group Minority
Virginia Innovation Partnership Corporation Not-For-Profit Venture Capital
Regional Accelerator & Mentoring Program Accelerator/Incubator
To view Chorda Pharma’s complete investors history, request access »

Chorda Pharma FAQs

  • When was Chorda Pharma founded?

    Chorda Pharma was founded in 2018.

  • Where is Chorda Pharma headquartered?

    Chorda Pharma is headquartered in Roanoke, VA.

  • What industry is Chorda Pharma in?

    Chorda Pharma’s primary industry is Drug Discovery.

  • Is Chorda Pharma a private or public company?

    Chorda Pharma is a Private company.

  • What is Chorda Pharma’s current revenue?

    The current revenue for Chorda Pharma is .

  • How much funding has Chorda Pharma raised over time?

    Chorda Pharma has raised $512K.

  • Who are Chorda Pharma’s investors?

    Common Wealth Angels, Virginia Innovation Partnership Corporation, and Regional Accelerator & Mentoring Program have invested in Chorda Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process